P

Inventor

CORKEY BRITTON KENNETH

US18 patents
⚠️ This page may combine multiple inventors who share the name “CORKEY BRITTON KENNETH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GILEAD SCIENCES INC

15 patents
US9067933B2Jun 30, 2015

Apoptosis signal-regulating kinase inhibitors

GILEAD SCIENCES INC25 citations92
US9676760B2Jun 13, 2017

Fused heterocyclic compounds as ion channel modulators

GILEAD SCIENCES INC7 citations84
US9598435B2Mar 21, 2017

Fused heterocyclic compounds as ion channel modulators

GILEAD SCIENCES INC9 citations84
US9193694B2Nov 24, 2015

Fused heterocyclic compounds as ion channel modulators

GILEAD SCIENCES INC11 citations84
US9458145B2Oct 4, 2016

Benzimidazole derivatives as bromodomain inhibitors

GILEAD SCIENCES INC12 citations82
US9403782B2Aug 2, 2016

Fused heterocyclic compounds as ion channel modulators

GILEAD SCIENCES INC4 citations73
US9255089B2Feb 9, 2016

Benzimidazolone derivatives as bromodomain inhibitors

GILEAD SCIENCES INC7 citations72
US9951065B2Apr 24, 2018

Benzimidazole and imadazopyridine carboximidamide compounds

GILEAD SCIENCES INC3 citations68
US11229638B2Jan 25, 2022

Therapeutic heterocyclic compounds

GILEAD SCIENCES INC0 citations61
US11040033B2Jun 22, 2021

Therapeutic heterocyclic compounds

GILEAD SCIENCES INC1 citations61
US9695192B2Jul 4, 2017

Fused heterocyclic compounds as ion channel modulators

GILEAD SCIENCES INC0 citations52
US9682998B2Jun 20, 2017

Fused heterocyclic compounds as ion channel modulators

GILEAD SCIENCES INC0 citations52
US11186579B2Nov 30, 2021

Therapeutic heterocyclic compounds

GILEAD SCIENCES INC0 citations50
US11098027B2Aug 24, 2021

Therapeutic heterocyclic compounds

GILEAD SCIENCES INC0 citations50
US10017501B2Jul 10, 2018

Benzimidazole derivatives as bromodomain inhibitors

GILEAD SCIENCES INC0 citations50

CORKEY BRITTON KENNETH

3 patents